Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 1/20 | 0.41 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.41 |
| ▸ | FEN1 | P39748 | 1/20 | 0.31 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | ESR1 | P03372 | 1/20 | 0.30 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4961265 | 0.74 | GABRA1 (0.56) | GABRA1GABRB2FEN1ESR1ESR2 | |
| Methylamine SCHEMBL27907243 | 0.72 | GABRA1 (0.54) | GABRA1GABRB2FEN1ESR1ESR2 | |
| SCHEMBL27932018 | 0.71 | GABRA1 (0.41) | GABRA1GABRB2FEN1ESR1ESR2 | |
| SCHEMBL9421916 | 0.71 | CYP3A4 (0.44) | CYP3A4TSHR | |
| SCHEMBL29429347 | 0.70 | GABRA1 (0.52) | GABRA1GABRB2HSP90AB1ESR1ESR2 | |
| SCHEMBL16527801 | 0.70 | GABRA1 (0.52) | GABRA1GABRB2FEN1ESR1ESR2 | |
| SCHEMBL3191260 | 0.70 | GABRA1 (0.52) | GABRA1GABRB2HSP90AB1ESR1ESR2 | |
| SCHEMBL6207216 | 0.69 | GABRA1 (0.41) | GABRA1GABRB2CYP3A4TSHR | |
| SCHEMBL13057531 | 0.69 | GABRA1 (0.50) | GABRA1GABRB2FEN1ESR1ESR2 | |
| SCHEMBL45861 | 0.68 | GABRA1 (0.68) | GABRA1GABRB2FEN1ESR1ESR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118340754-B | Compound for treating heart failure and related diseases and application thereof | 源道医药(苏州)有限公司 | 2025-03-11 | — | — | CN | disclosed |
| CN-119490387-A | Compounds for the treatment of pain-related diseases | 源道医药(苏州)有限公司 | 2025-02-21 | — | — | CN | disclosed |
| CN-118340754-A | Compound for treating heart failure and related diseases and application thereof | 源道医药(苏州)有限公司 | 2024-07-16 | — | — | CN | disclosed |